Form D · Private Equity Fund
Pharmakon Opportunities LP
New York, NY · CIK 0001742631
Offering snapshot reported Jun 15, 2018 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-314703
The Issuer's confidential offering materials fully discuss the fees Pharmakon Advisors, LP, the investment manager of the Issuer, and the general partner are entitled to.
Source: Form D, filed Jun 15, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pedro Gonzalez De Cosio | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
110 East 59 Th Street 33 Rd Floor
New York, NY, 10022
New York, NY, 10022